Status:
COMPLETED
Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
All Genders
20-80 years
Phase:
PHASE1
Brief Summary
The primary purpose of this study is to assess the safety and tolerability of AZD2516 following administration of a single dose.
Eligibility Criteria
Inclusion
- Healthy white males or non-fertile females between 20 to 45 years and 65 to 80 years old.
- Weight between 50 to 100 kg and a body mass index (BMI) between 19 to 28 kg/m2
Exclusion
- History of previous or ongoing psychiatric disease.
- Abnormalities in ECG that may interfere with interpretation of data.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00754715
Start Date
September 1 2008
End Date
December 1 2008
Last Update
December 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Stockholm, Sweden